MAPK14 and hepatocellular carcinoma: Subsequently, Rudalska et al. employed in vivo RNAi screening in mouse models of HCC to identify that the activation of Mapk14 promotes resistance through the Mek-Erk and Atf2 signaling pathways (Rudalska et al., 2014).